首页> 外文期刊>Bioorganic and medicinal chemistry >Design synthesis and structure-activity relationship of 5-substituted (tetrahydronaphthalen-2yl) methyl with N-phenyl-N-(piperidin-2-yl) propionamide derivatives as opioid ligands
【24h】

Design synthesis and structure-activity relationship of 5-substituted (tetrahydronaphthalen-2yl) methyl with N-phenyl-N-(piperidin-2-yl) propionamide derivatives as opioid ligands

机译:以N-苯基-N-(哌啶-2-基)丙酰胺衍生物为类阿片配体的5-取代的(四氢萘-2-基)甲基的设计合成及构效关系

获取原文
获取原文并翻译 | 示例
           

摘要

Here, we report the design, synthesis and structure activity relationship of novel small molecule opioid ligands based on 5-amino substituted (tetrahydronaphthalen-2-yl)methyl moiety with N-phenyl-N-(piperidin-2-yl)propionamide derivatives. We synthesized various molecules including amino, amide and hydroxy substitution on the 5th position of the (tetrahydronaphthalen-2-yl) methyl moiety. In our further designs we replaced the (tetrahydronaphthalen-2-yl)methyl moiety with benzyl and phenethyl moiety. These N-phenyl-N-(piperidin-2-yl)propionamide analogues showed moderate to good binding affinities (850-4 nM) and were selective towards the mu opioid receptor over the delta opioid receptors. From the structure activity relationship studies, we found that a hydroxyl substitution at the 5th position of (tetrahydronapthalen-2yl)methyl group, ligands 19 and 20, showed excellent binding affinities 4 and 5 nM, respectively, and 1000 fold selectivity towards the mu opioid relative to the delta opioid receptor. The ligand 19 showed potent agonist activities 75 +/- 21 nM, and 190 +/- 42 nM in the GPI and MVD assays. Surprisingly the fluoro analogue 20 showed good agonist activities in MVD assays 170 +/- 42 nM, in contrast to its binding affinity results. (C) 2015 Elsevier Ltd. All rights reserved.
机译:在这里,我们报道基于5-氨基取代的(四氢萘-2-基)甲基部分与N-苯基-N-(哌啶-2-基)丙酰胺衍生物的新型小分子阿片样物质配体的设计,合成和结构活性关系。我们合成了各种分子,包括在(四氢萘-2-基)甲基部分的第5位上的氨基,酰胺和羟基取代基。在我们的进一步设计中,我们用苄基和苯乙基部分取代了(四氢萘-2-基)甲基部分。这些N-苯基-N-(哌啶-2-基)丙酰胺酰胺类似物显示出中等至良好的结合亲和力(850-4 nM),并且对δ-阿片样物质受体对μ-阿片样物质受体具有选择性。从结构活性关系研究中,我们发现(四氢萘二甲酰基-2基)甲基的第5位羟基(配体19和20)分别具有出色的结合亲和力4和5 nM,对mu阿片样物质的选择性是1000倍相对于δ阿片受体。在GPI和MVD测定中,配体19显示出强效激动剂活性75 +/- 21nM和190 +/- 42nM。令人惊讶地,与其结合亲和力结果相反,氟类似物20在MVD测定170 +/- 42nM中显示出良好的激动剂活性。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号